Skip to main content
. 2014 May 27;7:165–170. doi: 10.2147/CCID.S37327

Table 2.

Incidence of adverse reactions at the application site in 1% of patients treated with tazarotene foam 0.1%

Adverse reactions at the application site Tazarotene foam, n=744 Vehicle foam, n=741
Patients with any adverse reaction, n (%) 163 (22) 19 (3)
Irritation 107 (14) 9 (1)
Dryness 50 (7) 8 (1)
Erythema 48 (6) 3 (<1)
Exfoliation 44 (6) 3 (<1)
Pain 9 (1) 0
Photosensitivity (including sunburn) 8 (1) 3 (<1)
Pruritus 7 (1) 3 (<1)
Dermatitis 6 (1) 1 (<1)